Gaetano Leto

Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors: a multicentre retrospective study (CoViDiab II)

R. Holman, F. Agrò, E. N. Cavallari, 2020, Cardiovascular Diabetology.

Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk

G. Beccuti, S. Piro, E. Orsi, 2024, The Lancet regional health. Europe.

Lack of Association between Serum Chitotriosidase Activity and Arterial Stiffness in Type 2 Diabetes without Cardiovascular Complications

L. D'Onofrio, S. Mazzaferro, E. Maddaloni, 2023, International journal of molecular sciences.

Clinical Features, Cardiovascular Risk Profile, and Therapeutic Trajectories of Patients with Type 2 Diabetes Candidate for Oral Semaglutide Therapy in the Italian Specialist Care

A. Filippi, A. Iovino, G. Beccuti, 2023, Diabetes Therapy.